Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

NGENNGEN
2 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in NERVGEN PHARMA CORP

BANK OF AMERICA CORP /DE/ holds 186,200 shares of NGEN (NERVGEN PHARMA CORP), worth $383,572 as of 2026-Q2. The position was decreased (-7.2% shares).

Current Value

$383,572

Current Shares

186,200

Total Value Change

-$372,901

Total Shares Change

-14,456

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
186,200
-7.2%
$383,5720.0%$2.06
0
2026-Q1
New
200,656
-
$756,4730.0%$3.95
34

Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, ROYAL BANK OF CANADA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used